Policy Reports / Position Papers / Legal Briefs

  1. Castle D, Bell J, Bubela T, Culver K, Hanner R, Phillips P (2013) Receptor Capacity for Biotechnology Innovation in Canada. Genome Canada Policy Brief No. 8.
  2. Bubela T, Geary J, Guebert J, Shelley J (2013) Workshop Report: Barcoding and Natural Health Products. Medicinal Plant Barcoding and Health Products Research: Moving the Debate Forward on Access and Benefit Sharing. Mexico City, February 12-13, 2013.
  3. AMICUS CURIAE BRIEF on genetic diagnostics for Breast Cancer (BRCA1 patents) with E. Richard Gold (Professor, Faculty of Law, McGill University), James P. Evans (Professor, Medical Genetics and Internal Medicine, University of North Carolina and Chair, Federal task force on impact of patents on genetic testing for the Secretary’s Advisory Committee on Genetics, Health and Society), and Dinanne Nicol (Vice-Dean of Law, University of Tasmania) submitted to the United States Supreme Court to support an application for certiori in the case of The Association for Molecular Pathology, et al.v. United States Patent and Trademark Office and Myriad Genetics
  4. AMICUS CURIAE BRIEF on genetic diagnostics for Breast Cancer (BRCA1 patents) with E. Richard Gold (Professor, Faculty of Law, McGill University) and James P. Evans (Professor, Medical Genetics and Internal Medicine, University of North Carolina and Chair, Federal task force on impact of patents on genetic testing for the Secretary’s Advisory Committee on Genetics, Health and Society) submitted to the United States Courts of Appeals for the Federal Circuit in the case of The Association for Molecular Pathology, et al.v. United States Patent and Trademark Office and Myriad Genetics.
  5. Li MD, Atkins H, Hafez M, Bieber M, Bubela T. Landscape of international translational stem cell research. Report for the Stem Cell Network and the Canadian Centre for Regenerative Medicine (2012).
  6. Callan B, Bubela T, Slater B, Gagnon MA, Morin JF, Belanger M, Gold ER. (2011) Impact of Intellectual Property Protection on Pharmaceutical Innovation. Submission of the Technical Proposal to Health Canada Strategis Policy Branch, Office of Pharmaceuticals Management Strategies. Response to RFP (1000121857). Prepared on behalf of The Innovation Partnership. 138 pp.
  7. Alberta Forum for Global Health Research. Global Health Research in Alberta: Global Reach, Local Impact. Submission to Alberta Innovates – Health Solutions for Strategic Planning Process, June 2010 [lead drafter].
  8. Bubela T, Gold ER, Morin, JF, Carbone J, Gagnon MA, Srulovicz T, Joly Y(2010) Evidence and Background Information to Inform Canada’s Approach to Public Health and Intellectual Property Issues in International Fora. Submission to Health Canada’s International Affairs Directorate (IAD) 94pp.
  9. Gold ER, Bubela, T,  Carbone J, Gagnon MA, Srulovicz T, Joly Y (2010) At the intersection of health and intellectual property: Issues, tools and directions for Health Canada. Submission to Health Canada: Bioethics, Innovation and Policy Integration Division, 71pp.
  10. Gold ER, Adams W, Bernier L, Bubela, T, et al. (2008) Toward a New Era for Intellectual Property: From Confrontation to Negotiation. A Report by The International Expert Group on Biotechnology, Innovation and Intellectual Property. (The Innovation Partnership, 2008). Online: http://www.theinnovationpartnership.org/en/ieg/report/

**This report made the top-ten downloaded papers on the SSRN database (Sept-Oct 2008) in the categories Health Law Journals and LSN Science, Technology & Innovation Research Papers.

  1. Bubela T and Strotmann A (2008) Designing Metrics to Assess Impacts and Social Benefits of Publicly Funded Research in Health and Agricultural Biotechnology. A Report to The International Expert Group on Biotechnology, Innovation and Intellectual Property. (The Innovation Partnership, 2008). Online: http://www.theinnovationpartnership.org/en/ieg/cases/
  2. Bubela T, Beas Rodriguez E, Metcalf C, Nnadozie K, Rodriguez E, Carbone J (2008) Respecting, Promoting, and Protecting Traditional Knowledge: A Comparative Case Study of Brazil, Kenya and Northern Canada. (2008) A Report to  The International Expert Group on Biotechnology, Innovation and Intellectual Property. (The Innovation Partnership, 2008). Online: http://www.theinnovationpartnership.org/en/ieg/cases/
  3. Morin, JF, Gold R, Bubela T, Bensimon C (2008) Governance Issues in Intellectual Property: the Jean Chretien Pledge of Africa Act. A Report to The International Expert Group on Biotechnology, Innovation and Intellectual Property. (The Innovation Partnership, 2008). Online: http://www.theinnovationpartnership.org/en/ieg/cases/
  4. Prepared on behalf of the North American Conditional Mouse Mutagenesis Project (NorCOMM) and the Canadian Mutant Mouse Repository (CMMR) (with Dr. Lauryl Nutter) “Response to the proposed New Substances Notification Regulations (Organisms): Revisions to Research Exemption”, Submission to the Government of Canada on impact of proposed regulatory changes on biomedical research community using genetically modified rodents as model organisms. January 22, 2008.
  5. Bubela, T.M. (1996) Management Supplement: ‘Social Effects of Sterilising Free-Ranging Vixens (VulpesvulpesL.) in Subalpine Australia’. Unpublished Report for the New South Wales National Parks and Wildlife Service.
  6. Bubela, T.M. (1995).  An Experimental Design for Fertility Control of  Wolves (Canis lupus) in the Aishihik Area, Southwest Yukon. Unpublished Report for Yukon Renewable Resources, Fish and Wildlife Branch.
  7. Bubela, T.M. and Wilson, B.C. (1993).  Population structure and habitat use of the broad-toothed rat Mastacomysfuscus Thomas at Crackenback Ridge, Thredbo, New South Wales.  Fauna Impact Survey for Kosciusko Thredbo Pty. Ltd.